Long-term pharmacological treatment shows promise against memory impairments in Down syndrome
In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, described that mice models for Down syndrome have more cannabinoid receptor 1 (CBR1) in some regions ...
7 minutes ago
0
0









